Lucid Diagnostics Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Matheis Dennis | — | Purchase | 100,000 | $1.02 | $102,000 | Aug 20, 2025 |
| Matheis Dennis | — | Purchase | 33,218 | $1.32 | $43,848 | May 21, 2025 |
| Matheis Dennis | — | Purchase | 187,098 | $1.30 | $243,227 | May 21, 2025 |
| O'Neil Shaun | President and COO | Award / Grant | 300,000 | — | — | Feb 20, 2025 |
| Aklog Lishan | Chief Executive Officer | Award / Grant | 300,000 | — | — | Feb 20, 2025 |
| SOKOLOV JACQUE J | — | Award / Grant | 112,800 | — | — | Feb 20, 2025 |
| Lapidus Stanley | — | Award / Grant | 112,800 | — | — | Feb 20, 2025 |
| Matheis Dennis | — | Award / Grant | 112,800 | — | — | Feb 20, 2025 |
| Cox James L | — | Award / Grant | 112,800 | — | — | Feb 20, 2025 |
| MCGRATH DENNIS M | Chief Financial Officer | Award / Grant | 300,000 | — | — | Feb 20, 2025 |
| Gordon Michael Adam | General Counsel and Secretary | Award / Grant | 300,000 | — | — | Feb 20, 2025 |
| White Debra | — | Award / Grant | 112,800 | — | — | Feb 20, 2025 |
| Sparks Ronald M | — | Award / Grant | 112,800 | — | — | Feb 20, 2025 |
| Gordon Michael Adam | General Counsel and Secretary | Award / Grant | 400,000 | — | — | May 7, 2024 |
| O'Neil Shaun | President and COO | Award / Grant | 400,000 | — | — | May 7, 2024 |
| MCGRATH DENNIS M | Chief Financial Officer | Award / Grant | 400,000 | — | — | May 7, 2024 |
| Aklog Lishan | Chief Executive Officer | Award / Grant | 400,000 | — | — | May 7, 2024 |
| PAVmed Inc. | — | Other | 3,331,747 | — | — | Feb 15, 2024 |
| PAVmed Inc. | — | Other | 3,331,771 | $1.40 | $4,664,479 | Jan 26, 2024 |
| Lapidus Stanley | — | Sale | 9,747 | $1.45 | $14,133 | Sep 25, 2023 |
| Lapidus Stanley | — | Sale | 3,405 | $1.45 | $4,937 | Sep 20, 2023 |
| Lapidus Stanley | — | Sale | 100 | $1.44 | $144 | Sep 20, 2023 |
| PAVmed Inc. | — | Other | 221,952 | $2.48 | $550,441 | Nov 30, 2022 |
| PAVmed Inc. | — | Other | 1,479,326 | $1.84 | $2,721,960 | Nov 30, 2022 |
| Lapidus Stanley | — | Sale | 16,864 | $1.70 | $28,669 | Sep 20, 2022 |
| Aklog Lishan | Chief Executive Officer | Award / Grant | 60,000 | — | — | Jan 7, 2022 |
| MCGRATH DENNIS M | Chief Financial Officer | Award / Grant | 60,000 | — | — | Jan 7, 2022 |
| PAVmed Inc. | — | Purchase | 571,428 | $14.00 | $7,999,992 | Oct 18, 2021 |
| Sparks Ronald M | — | Award / Grant | 84,660 | — | — | Oct 18, 2021 |